Document Detail


Pharmacotherapy in congestive heart failure: Vasopeptidase inhibition and its role in congestive heart failure.
MedLine Citation:
PMID:  12029184     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Vasopeptidase inhibition--that is, the dual inhibition of ACE and neutral endopeptidase-reduces blood pressure in a potent manner. Preliminary studies suggest that vasopeptidase inhibition can also effectively treat congestive heart failure. Additional corroborating studies to support the use of vasopeptidase inhibition in heart failure are now underway. (c)2000 by CHF, Inc.
Authors:
D A Sica
Related Documents :
9308504 - Impact of medication nonadherence on coronary heart disease outcomes. a critical review.
6468194 - Isolated ischemic necrosis of the cecum in patients with chronic heart disease.
6490214 - Myocardial involvement in acromegaly.
9069774 - Pathophysiology of congestive heart failure in esrd.
15660694 - Assessment of myocardial viability using myocardial contrast echocardiography.
22920484 - Triggers and anatomical substrates in the genesis and perpetuation of atrial fibrillation.
Publication Detail:
Type:  JOURNAL ARTICLE    
Journal Detail:
Title:  Congestive heart failure (Greenwich, Conn.)     Volume:  6     ISSN:  1751-7133     ISO Abbreviation:  Congest Heart Fail     Publication Date:    2000 May-Jun
Date Detail:
Created Date:  2002-May-24     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9714174     Medline TA:  Congest Heart Fail     Country:  -    
Other Details:
Languages:  ENG     Pagination:  158-163     Citation Subset:  -    
Affiliation:
Division of Clinical Pharmacology and Hypertension, Medical College of Virginia of Virginia Commonwealth University, Richmond, VA 23298.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Are all beta blockers the same for heart failure?
Next Document:  Difficult cases in heart failure: Bridge to beta blockade in severe heart failure: the use of phosph...